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Abstract
Melanopsin photoreception plays a vital role in irradiance detection for non-image forming responses to light. However,
little is known about the involvement of melanopsin in emotional processing of luminance. When confronted with a
gradient in light, organisms exhibit spatial movements relative to this stimulus. In rodents, behavioural light aversion (BLA)
is a well-documented but poorly understood phenomenon during which animals attribute salience to light and remove
themselves from it. Here, using genetically modified mice and an open field behavioural paradigm, we investigate the role
of melanopsin in BLA. While wildtype (WT), melanopsin knockout (Opn4
2/2) and rd/rd cl (melanopsin only (MO)) mice all
exhibit BLA, our novel methodology reveals that isolated melanopsin photoreception produces a slow, potentiating
response to light. In order to control for the involvement of pupillary constriction in BLA we eliminated this variable with
topical atropine application. This manipulation enhanced BLA in WT and MO mice, but most remarkably, revealed light
aversion in triple knockout (TKO) mice, lacking three elements deemed essential for conventional photoreception (Opn4
2/2
Gnat1
2/2 Cnga3
2/2). Using a number of complementary strategies, we determined this response to be generated at the
level of the retina. Our findings have significant implications for the understanding of how melanopsin signalling may
modulate aversive responses to light in mice and humans. In addition, we also reveal a clear potential for light perception in
TKO mice.
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Introduction
In the 1920’s, Crozier and Pincus showed that neonatal rats
with closed eyelids will move away from bright light along a
gradient towards a less intensely illuminated target [1]. Adult rats
retain an aversion to light [2,3], so strong that it can be used as a
motivating factor in behavioural learning paradigms [4]. Like rats,
adult mice also show behavioural light aversion (BLA) to acute
(10–30 mins) light exposure in the open field [5,6]. Using mice, the
‘‘light/dark box test’’ has been employed extensively in drug
development to identify putative anxiolytic compounds (see [5],
reviewed in [7]) and more recently to investigate human
photophobia in mouse models of migraine [8,9]. Despite the
widespread application of this behavioural phenomenon, and its
undoubted importance to the lives of nocturnal animals, little is
known about the neural circuitry mediating BLA in rodents.
Although one study to date has implicated both subcortical and
cortical processing [10], the contribution of different photorecep-
tive components from the retina remains unclear.
In the mammalian retina, rods/cones of the outer retina are
known to mediate image-forming vision [11,12], while photore-
ceptive melanopsin-expressing retinal ganglion cells (mRGCs) of
the inner retina sub serve most non-image-forming responses to
light [13,14,15,16,17]. If the eyes are enucleated bilaterally, then
BLA in rats is abolished [10]. To date, only a few studies shed light
on the important question of whether melanopsin alone could
mediate this primitive non-image-forming response. These studies,
from a variety of animal models, report mixed conclusions about a
potential role for melanopsin in BLA.
A recent study investigating the role of melanopsin in non-
image forming functions found that targeted destruction of
melanopsin cells had no impact on the light:dark preference of
mice [18]. This is in line with data from RCS rats showing a
progressive loss of BLA over time, with no response detectable by
7 months [19]. Another study using rd mice also failed to report a
significant light aversion response following exposure to illumina-
tion of 2800 Lux [20].
In contrast, spatial responses to light have been reported in rd
mice given the choice between light and dark living/nesting areas
over a 22 h period [21]. Here, retinal degenerate mice spent
significantly more time in the dark than the illuminated area, a
response that could be eliminated by enucleation. However, as rd
mice retain a significant population of remodelled cones with
identifiable presynaptic stuctures [22,23,24,25] they are unsatisfac-
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we employ the rd/rd cl mouse, which lacks both rods and cones [15].
Melanopsin is a retinaldehyde-based, invertebrate-like photopig-
ment [26,27] involved with mediating many responses to light that
require a measure of general environmental irradiance [14,15,
28,29,30] and more recently, the ability of light to modulate sleep
[31,32,33]. Importantly, an associative learning (Pavlovian condi-
tioning) paradigm has shown that rd/rd cl mice can gradually learn to
use a brief light stimulus to predict the onset of electric shocks [34].
Although melanopsin cells are thought to project mainly to
subcortical, non-image forming centres of the brain, they may also
signal luminance information to the visual cortex [35,36,37,38].
In humans, light aversion is often referred to as photophobia, a
clinical term describing pain onset following light exposure in a
number of conditions including migraine headache [39,40,41].
Recently, the melanopsin system has been implicated in the
potentiation of migraine by light in blind patients [42] and although
little is known about the neural circuitry of photophobia it isgenerally
considered to require a convergence of information from optic and
trigeminal nerves with associated cortical processing [40,42,43,44]. In
addition, because sensory trigeminal afferents innervate muscles of
the iris, sustained constriction caused by the pupillary light reflex
(PLR) has also been implicated in causing the ocular discomfort felt
following exposure to bright lights [40,41,45]. The term photophobia
is also used to describe the sensation felt when we, as humans, enter
an environment which is subjectively appraised as being ‘‘too bright’’,
eliciting aversive behavioural responses such as looking away from
bright light and squinting [46,47,48].
Our goal in the present study was to determine the extent to
which melanopsin mediates BLA in mice. To achieve this, we
developed a variation on an established protocol for measuring
light aversion in mice [6], which now takes into account the
behaviour of animals placed into complete darkness. We tested
naı ¨ve wildtype (WT) mice, rd/rd cl mice (hereafter referred to as
melanopsin only (MO)) [14,31], melanopsin knockout (MKO)
mice (Opn4
2/2) [30] and as a control for the absence of light
perception, triple knockout (TKO) mice, lacking melanopsin and
functional rods/cones (Opn4
2/2 Gnat1
2/2 Cnga3
2/2). These mice
have no significant PLR, circadian photoentrainment or masking
responses [49]. In order to investigate if pupillary constriction is
causally related to BLA, we also equalised this variable across
genotypes by applying atropine bilaterally to the eyes.
Our experiments show that melanopsin alone can mediate a
behavioural aversion to light that is associated with neural
activation in the extended visual cortex. Analysis of temporal
kinetics reveals that melanopsin acts slowly to increase light
aversion over time, whereas rods/cones drive a more immediate
aversive response. While MKO mice remain capable of BLA our
analysis reveals that rods/cones and melanopsin are required for
an aversive response characteristic of WT animals. Surprisingly,
the addition of atropine increased BLA in WT, MO and TKO
mice, with this new light perception in TKO’s being associated
with an enhancement of residual retinal activity. The retinal origin
of light aversion behaviour in TKO mice was further investigated
by either eliminating BLA with bilateral axotomy or generating a
response comparable to that seen in wildtype animals by
specifically activating retinal neurons using Channelrhodopsin-2.
Results
Melanopsin alone can drive the behavioural aversion to
light
Animals were tested for BLA for 30 minutes in the open field
apparatus shown in Figure 1A. This behaviour was assessed by
comparing time spent in the dark back-half (BH) when the front-
half (FH) was illuminated (light FH) with control conditions when
the FH was maintained in darkness (dark FH).
Over the whole trial, WT normally-sighted animals spend the
majority of their time (67%) in the dark BH of the arena when the
FH is illuminated (Figure 1B). This is also significantly more time
(p,0.001) than when the FH is maintained in darkness during
which they spend only 34% of the time in the BH. The rd/rd cl
animals, with only melanopsin as a functional photopigment (MO)
do not spend the majority of their time in the dark when the FH is
illuminated (46%), however a significant light-aversion response is
revealed when this is compared to the amount of time that is spent
in the BH when there is no illumination (27%) (p,0.01).
This result, together with previous observations of an impair-
ment to BLA following lesions of visual cortex [10] prompted us to
examine if melanopsin alone could drive activation of this
structure in mice. This was achieved by examining light-induced
c-Fos in the visual cortex of MO animals, a technique previously
validated for normally sighted mice [50]. Here, using the same
light source as that used for behavioural testing, we found a clear,
melanopsin-driven c-Fos induction in medial visual/retrosplenial
cortex (Figure S1).
Melanopsin is not required for the behavioural aversion
to light
As seen in Figure 1, rods/cones also play a major role in BLA.
When the behaviour of the congenic MO and WT mice are
compared by two-way ANOVA there is a significant effect of
genotype (p,0.01) and of light (p,0.0001), with Bonferroni’s
multiple comparison tests confirming a significant reduction in
time spent in the dark BH when the FH is illuminated in the MO
(46%) compared to the WT (67%) mice (p,0.01). In control
conditions, when the entire arena is in darkness there is no
significant difference in behaviour between MO and WT mice,
both seeming to retain a preference for the FH.
Animals lacking melanopsin (MKO) spend significantly more
time (60%, p,0.05) in the dark BH when light is on in the FH
(Figure 1B), than when there is no illumination (only 28% of time
spent in BH). This finding shows that although melanopsin alone
can mediate BLA, the presence of this photopigment is not a
requirement for this response to occur. As anticipated, in TKO
mice (lacking melanopsin and normal rod/cone function), there is
no response to illumination in the FH, with these mice spending
similar amounts of time (p.0.05) in the BH whether the FH is in
darkness or light (29 versus 21% of the time).
Interestingly, regardless of whether the light was on or off, TKO
mice spend most of their time in the open FH of the arena, as do
the other genotypes in the complete darkness control condition.
This phenomenon holds true regardless of which side of the arena
animals are first placed (data not shown). To the best of our
knowledge, this consistent behaviour has not been reported
previously and should be taken into account when interpreting
data derived from light:dark choice tests of a similar design to ours.
Temporal kinetics of light aversion in mice
To investigate the behaviour of mice during the course of the
30-minute trial, data were binned into 6, 5-minute bins
throughout the trial (Figure 2A–D). Results of the associated
regression analysis are summarised in table 1. Under control
conditions (complete darkness), in all genotypes, animals failed to
change the amount of time spent in the BH (slopes of regression
lines are not significantly non-zero). However, when there is light
in the FH of the arena, both WT and MO mice show a positive
correlation with duration of the trial, spending more time in the
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PLoS ONE | www.plosone.org 2 November 2010 | Volume 5 | Issue 11 | e15009Figure 1. Role of melanopsin in the behavioural aversion to light in mice. (A) Open field apparatus: animals were placed into the front-half
(FH) of the arena and remained there for 30 minutes. Time spent in the back-half (BH) of the arena was recorded. (B) and (C) Average (6SEM)
percentage of time spent in the dark BH of the arena during the 30-minute trial. The FH is either illuminated, white bars (light FH), or in darkness,
black bars (dark FH). (B) In untreated animals photophobic behaviour is evident in wildtype (WT), melanopsin only (MO) rd/rd cl mice, and melanopsin
knockout (MKO) mice. Triple knockout (TKO) mice, lacking melanopsin and functional rods and cones show no aversion to light. (C) Atropine
significantly increases aversive behaviour in WT, MO, and TKO mice. In MKO mice, atropine increases the average aversive behaviour but this does not
reach significance. Atropine does not significantly affect behaviour when the FH is in darkness in any of the genotypes. Stars (*) indicate significance
levels (Student’s t-test): * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0015009.g001
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control conditions over the course of the trial, two–way repeated
measures ANOVA (RM ANOVA) was carried out on data from
each genotype, the results of Bonferroni post-tests are indicated on
the graphs in Figure 2.
The WT (Figure 2A) and MO (Figure 2B) mice show a similar
pattern of behaviour over the course of the trial, with the RM
ANOVA test revealing a significant effect of time (WT p,0.01,
MO p,0.001), light (WT p,0.001, p,0.01) and an interaction
between time X light (WT p,0.05, MO p,0.05). In the last 5
minutes of the trial (minutes 25–30) the WTs and MOs spend the
highest proportion of their time in the dark (87% WTs and 62%
MOs). It is however clear when comparing the behaviour of
WTs and MOs that melanopsin does not mediate all aspects of
normal light aversion behaviour. Unlike MOs, the WT mice
show a significant aversive response during the first 5 minutes of
the trial and spend a higher proportion of their time in the dark
BH.
As shown in Figure S2, aged MO animals retain their BLA,
despite a well-documented loss of melanopsin cells with advancing
age in these animals [51,52]. Interestingly, aging alters the
behaviour of MO mice over the duration of the trial, so that
during the first 5 minutes of the trial light aversion is intensified in
older MOs compared to younger animals (Figure S2B). This result
is of note and implies an increase in the potency of melanopsin
signalling in retinal dystrophy with advancing age.
In MKO mice we found no significant correlation with duration
ofthe trialand time spentinthedarkBH.From the beginningtothe
end of the trial these mice spent 60% of their time in the back-half,
similar to their overall average (Figure 2C). For this group of mice
RM ANOVA showed a significant effect of light (p,0.05), but not
for duration of trial or the interaction term light X time. As
expected, the TKO mice did not display a significant aversion to
light, with RM ANOVA showing no significant effect of light, time
or the interaction term, with no differences between light FH and
dark FH by Bonferroni post-tests. However, rather curiously, over
the 30-minute trial duration, TKO mice do show a positive
correlation with respect to the amount of time spent in the dark BH
of the arena when the FH is illuminated (see Figure 2D and table 1).
In summary, when rods and cones are absent, melanopsin is
capable of driving a slower onset BLA that is only clearly revealed
after 15–20 minutes. Conversely, in the absence of melanopsin,
animals retaining significant light aversion lack the positive
correlation over time. Animals lacking melanopsin and properly
functioning rods and cones (TKO) do not exhibit significant light
aversion. Therefore, in order to display the aversion to light
characteristic of their species, rodents must possess rods/cones and
the photopigment melanopsin.
Ocular application of atropine enhances light aversion
In order to investigate the impact of eliminating the variable of
pupillary constriction on BLA, atropine drops were applied
Figure 2. Temporal kinetics of the behavioural aversion to light in mice. Graphs showing time spent in the dark back-half (BH) of the arena
over the course of the 30-minute trial. Data are binned into 6, 5-minute bins throughout the trial, with y-axis showing average (6SEM) percentage
time spent in the dark BH. (A–D) shows data from untreated animals, and (E–H) after bilateral application of atropine drops. (A) and (E) WT, (B) and
(F)M O( rd/rd cl), (C) and (G) MKO (Opn4
2/2) and (D) and (H) TKO (Opn4
2/2 Gnat1
2/2 Cnga3
2/2). White triangles, trials when the front-half (FH) is in
light, black triangles, trials when the FH is in darkness. Results of the regression analyses are shown in table 1. Stars (*) indicate significance levels
(Bonferroni post tests, light FH v dark FH at each time point): * p,0.05; ** p,0.01; *** p,0.001.
doi:10.1371/journal.pone.0015009.g002
Table 1. Regression analysis of temporal kinetics of light aversion in mice.
Genotype Treatment Significant non-zero slope (p)r
2 Slope
WT Light Untreated ,0.05 0.68 1.0560.36
WT Dark Untreated .0.05 - -
MO Light Untreated ,0.01 0.86 0.9760.20
MO Dark Untreated .0.05 - -
MKO Light Untreated .0.05 - -
MKO Dark Untreated .0.05 - -
TKO Light Untreated ,0.05 0.75 0.5660.16
TKO Dark Untreated .0.05 - -
WT Light Atropine ,0.05 0.78 1.0160.27
WT Dark Atropine .0.05 - -
MO Light Atropine ,0.0001 0.99 1.4660.07
MO Dark Atropine .0.05 - -
MKO Light Atropine ,0.01 0.87 0.8860.17
MKO Dark Atropine .0.05 - -
TKO Light Atropine ,0.05 0.70 0.3860.12
TKO Dark Atropine .0.05 - -
TKO Light Axotomy/Atropine .0.05 - -
TKO Dark Axotomy/Atropine .0.05 - -
TKO Light AAV2-ChR2V ,0.05 0.66 0.7860.28
doi:10.1371/journal.pone.0015009.t001
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into our open field arena. Other mydriatics were tested initially
(e.g. phenylephrine, and tropicamide), however these agents were
found to be either too short acting for the 30-minute trial and/or
to cause mild distress, as such they were deemed unsuitable for use
in combination with behavioural testing. Atropine on the other
hand was ideal for this experiment as it relaxes the circular muscles
of the iris to cause a painless and long-lasting mydriasis [53].
The application of atropine to the eyes of experimental animals
produced no outward signs of discomfort and resulted in sustained
pupil dilation. Figure 3A shows the PLR of MO mice to white light
illumination (intensity-matched to that found in the experimental
arena), following atropine application, the pupil no longer
constricts. Unlike the other three genotypes tested here, TKO
mice already lack pupil constriction, with neither atropine nor
illumination able to change their pupil area (Figure 3B). It should
be noted that the constriction mechanism itself in TKO mice
remains intact, as demonstrated previously by application of the
parasympathetic agonist carbachol [49].
As shown in Figure 1C, when atropine is applied prior to
testing, all genotypes (including TKO mice) exhibit significant
BLA, spending more time in the dark BH when the FH is
illuminated. The influence of light and atropine in each genotype
was assessed by two-way ANOVA followed by Bonferroni’s
multiple comparison tests. In the WT and MO there is a
significant effect of light (WT, p,0.001; MO p,0.001) and
atropine (WT, p,0.001; MO, p,0.01), there is also a significant
interaction between light X atropine only in MO (WT, not
significant; MO p,0.05). Post hoc tests reveal that with atropine
application, light aversion is significantly increased (p,0.01) from
67% to 86% in WTs, and from 46% to 74% (p,0.001) in MOs.
Atropine did not have a significant effect on behaviour in the dark
in either the WTs or MOs.
Comparing the WT and MO behaviour by two-way ANOVA
(factors: light and genotype) there is still an effect of both light
(p,0.0001) and genotype (p,0.05) but by post hoc comparison
testing the MO is no longer significantly less light aversive than the
WT as was the case in the non atropine treated animals. Atropine
application is therefore greatly enhancing melanopsin- mediated
BLA, such that MOs lacking rods and cones are now behaving
much more like WT animals. By contrast, in MKO mice atropine
does not significantly enhance light aversion (Figure 2C), with two-
way ANOVA revealing a significant effect of light (p,0.01) but not
of atropine. In these animals, post hoc testing confirms there is no
statistically significant change in light aversion with atropine
application when either the FH is illuminated or in control
conditions when the entire arena is in darkness.
Rather surprisingly, two-way ANOVA reveals a significant
effect of atropine (p,0.05) and a significant interaction between
light and atropine (p,0.05) in the TKO mice. Post hoc testing
confirms that there is a significant increase in light aversion
behaviour with the application of atropine (p,0.01) from 21% to
53% of time spent in the dark BH when the light is on. Again,
atropine had no influence on behaviour in control conditions
when the FH is in darkness.
Following atropine application, all the genotypes now show a
positive correlation over the course of the trial spending more time
in the dark BH as the trial progresses when the FH is illuminated
Figure 3. Effect of atropine on pupil size. In (A)M O( rd/rd cl), and (B) TKO (Opn4
2/2 Gnat1
2/2 Cnga3
2/2) mice. Images below each graph
illustrate pupil size pre- and post- light stimulation with atropine (Atr.) or without atropine (No Atr.) application in the two genotypes.
doi:10.1371/journal.pone.0015009.g003
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WT mice spend 92% of the time in the dark BH, and at this point
the MO is almost indistinguishable, spending 91% of the time in
the dark. The MKO also spends most time in the dark at this point
(76%), and surprisingly the TKO also exhibits quite a striking
aversion to light, spending 60% of the time in the dark in the final
5 minutes of the trial. Two–way RM ANOVA of atropine treated
WT (Figure 2E), MO (Figure 2F), and MKO (Figure 2G),
behaviour reveals a significant effect of time (WT, p,0.01; MO,
p,0.0001; MKO, p,0.001) light (WT, p,0.001; MO p,0.001;
MKO, p,0.001) and an interaction between time X light (WT,
p,0.05; MO, p,0.01; MKO p,0.01). The two-way RM
ANOVA on atropine treated TKO mice (Figure 2H) shows there
to be a significant effect of light (p,0.05) and a significant
interaction between light X time (p,0.05) on BLA. It is clear that
towards the end of the trial, TKO mice now spend significantly
more time in the dark BH when the light is on in the FH than in
control conditions with the dark FH.
The mechanism by which atropine is increasing light aversion in
TKO mice is not readily apparent. In the other three genotypes
(WT, MO and MKO), atropine application is causing pupil
dilation and as such, their enhanced behavioural response could
be attributed to more light entering the eye. However, in TKO
mice this cannot be the case as we found their pupils to be fully
dilated regardless of atropine administration (Figure 3B). As such,
atropine would appear to be enhancing some residual light
perception retained in these animals. This may be at the level of
the retina or, alternatively, through a more systemic route acting
on more central components of the visual system. Indeed, recent
work from the Lucas laboratory has identified a small but
significant electrophysiological response to light, both at the level
of the ERG and the dorsal lateral geniculate nucleus of the
thalamus [54]. To test the hypothesis that atropine might be
influencing responsiveness of the TKO retina directly we carried
out ERG recordings on these mice with and without atropine.
Atropine does indeed significantly enhance the b-wave amplitude
in TKO mice (Figure 4).
Aversion to light in TKO mice is driven by signals from
the retina
In order to determine if the atropine-enhanced BLA of TKO
mice was being driven by signals from the retina (as opposed to a
local-systemic action of this drug on the brain), we used two
complementary approaches: 1. Eliminate retinal input to the brain
using bilateral axotomy and 2. Specifically render retinal neurons
light sensitive using a non-pharmacological agent (the microbial
opsin Channelrhodopsin-2 (ChR2)), unable to potentiate the function
of more remote components of the visual system.
For axotomy, in order to minimise the trauma associated with
established procedures [55,56], we developed a novel technique
that uses an intraocular, sub-retinal approach (see diagram in
Figure 5A). As shown in Figure 5B and Figure S3, at 9 days post-
axotomy, our technique has obliterated calretinin-positive retinal
axons innervating the brain, confirming successful axotomy.
As shown in Figure 5C, after axotomy and subsequent atropine
application, TKO mice no longer show a significant light aversion
response over the whole trial (light FH versus dark FH Student’s t-
test p.0.05). Over the course of the trial there is also no
correlation with the amount of time the animals spend in the dark
BH with light FH or dark FH (see Figure 5D; Table 1). Also, Two-
way RM ANOVA did not reveal any significant effects of light or
trial duration on the time spent in the dark BH. These data show
that axotomy abolishes the atropine-induced BLA in TKO mice.
In order to confirm that enhanced retinal output is sufficient to
drive BLA in TKO mice, we rendered their retinae directly light
sensitive. This was achieved by transfecting inner retinal neurons
with ChR2 using an intravitreal injection of an adeno-associated
viral vector (AAV), which causes Channelrhodopsin-2/Venus (ChR2V)
fusion protein expression in the retinal ganglion cells [57,58]. The
expression of ChR2V gene is under the control of the CAG
promoter which results in approximately 30% of retinal ganglion
cells expressing ChR2 [58]. It has previously been demonstrated
that the viral construct we use here (AAV2-ChR2V) restores visual
responses in rodents with degenerate rods/cones, while the Venus
fluorescent reporter alone (AAV2-Venus) does not [57,58].
Figure 4. Atropine augments an ERG b-wave preserved in TKO mice. (A) b-wave amplitude of flash ERG responses in the presence and
absence of atropine drops. A small but significant increase in the ERG b-wave amplitude was apparent following application of atropine drops (data
presented as mean6SEM; n=5 for each group). This is demonstrated in the average of all ERG responses in each group, shown in (B), atropine
treated shown in grey, and untreated in black (scale bars: y-axis=25 mV, x-axis=50 ms; n=5 for each group).
doi:10.1371/journal.pone.0015009.g004
Melanopsin in Behavioural Light Aversion
PLoS ONE | www.plosone.org 7 November 2010 | Volume 5 | Issue 11 | e15009As shown in Figure 6, 2 months post-bilateral-injection of
AAV2-ChR2V into adult TKO mice, cells across the entire inner
retina were transduced to express ChR2V (green). In Figure 6B
the red cells are stained for b-galactosidase, the reporter gene that
replaces the melanopsin gene in TKO mice. Interestingly, by
double-labelling in this fashion we very rarely encountered b-
galactosidase positive cells that had been transduced to express the
microbial opsin (,5 cells per retina).
As shown in Figure 6C, following ChR2V transduction, TKO
mice (denoted AAV2-ChR2V TKO) now show an aversion to light
similar to that of WT mice (WTs spend 6764% (mean6SEM)
and AAV2-ChR2V TKOs spend 68610% (mean6SEM) in the
dark back half when the front half is illuminated). The AAV2-
ChR2V TKO mice also exhibit a positive correlation in their
behaviour over the duration of the trial (Figure 6D), spending most
time in the dark BH at the end of the trial (74%). Two-way RM
ANOVA comparing the untreated to AAV2-ChR2V treated TKOs
reveals a significant effect of treatment (p,0.001), and a significant
effect of time (p,0.05). Bonferroni post tests show that at all time
points during the trial, AAV2-ChR2V TKOs are significantly more
averse to light than the untreated animals in the light (Figure 6D).
Importantly for addressing the role of pupillary constriction in
BLA, the transduced mice exhibited this strong aversion to light in
the absence of a detectable PLR (Figure S4).
Discussion
The photopigment melanopsin has an established role in non-
image forming behavioural responses to light such as circadian
photoentrainment, negative masking and the induction of sleep
[15,28,31,32,33]. It has also been shown to be sufficient for the
acquisition of a Pavlovian association between light and
Figure 5. Axotomy abolishes the atropine-induced light aversion response in TKO mice. (A) Diagramatic illustration of the axotomy
technique (image modified from [75] ), a swift back and forth movement of the needle severs both the optic nerve and central retinal artery. (B)
Immunoreactivity for calretinin positive retinal afferents (red) is abolished in the superficial gray (SuG) and the optic nerve (Op) layers of the superior
colliculus of a bilaterally axotomised TKO (bottom) compared to an unoperated contol (top). Collicular sections are 23.88 mm from bregma [76],
scale bar is 200 mm. (C) Behavioural aversion to light in atropine-treated TKO mice is abolished in bilaterally axotomised animals. (D) Time spent in
the dark back half (BH) of the arena over the course of the 30-minute trial. White triangles, from trials when the front-half (FH) is in light, black
triangles when the FH is in darkness. Abbreviations: bsc, brachium of the superior colliculus; Ch-RPE, choroid retinal pigment epithelium; CRA, central
retinal artery; ns, not significant; OA, ophthalmic artery, ON, optic nerve; Sc, sclera.
doi:10.1371/journal.pone.0015009.g005
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mice, we confirm a new and important role for melanopsin in the
attribution of emotional salience to light. Quite unexpectedly, our
investigations also reveal a capacity for light perception/BLA in
mice lacking three components deemed necessary for photore-
ception.
Melanopsin mediates a slow behavioural aversion to
light
As reported for normally sighted animals in previous studies, we
found a clear aversion to light by WT mice within the first 5
minutes of our test. However, in MO mice, where melanopsin
alone drives this response there is a slower, more gradual BLA
over time. The majority of light:dark testing paradigms used to
date employ short trials (5–10 min duration) and we suggest that
this may be one factor in the failure to report light aversion in
previous studies using retinal degnerate rodents [19,20]. Our
results are however consistent with those from a 22 h experiment
suggesting a role for melanopsin in the preference displayed by rd/
rod-ablated mice for a darkened nesting compartment [21].
Additionally, our data from MO mice shows that melanopsin-
driven BLA has a strong positive correlation over time,
potentiating light aversion over the course of our trial.
As with many other non-image forming responses to light, our
data from MKO mice shows that melanopsin is not required for
BLA to occur. However, these animals lack a positive correlation
Figure 6. Channelrhodopsin-2 expression in the inner retina of TKO mice causes the induction of behavioural light aversion. (A) and
(B) AAV2 transduced expression of Channelrhodopsin-2/Venus fusion (ChR2V) protein (green) in the ganglion cell layer of a TKO retina (AAV2-ChR2V
TKO). (A) Transverse retinal section, ChR2V is visualised in many cells of the ganglion cell layer. Scale bar 20 mm( B) Immunohistochemistry on flat
mount retina (focussing on the ganglion cell layer) for b-galactosidase (red) with ChR2V in green. Scale bar 100 mm. (C–D) Light aversion behaviour in
the AAV2-ChR2V TKO. In these two graphs the comparison is between transduced and untreated animals when there is illumination in the front-half
(FH). (C) Time spent in the dark back-half (BH) of the arena during the total 30 minutes of the trial. (D) Time spent in the dark (BH) of the arena over
the course of the 30-minute trial. Stars (*) indicate significances (** p,0.01; *** p,0.001).
doi:10.1371/journal.pone.0015009.g006
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outer retinal signalling as this behaviour progresses. We also found
that older MO mice lose the positive correlation in BLA across
time due to an enhanced light aversion in the first five minutes, an
intriguing finding that suggests increased potency of melanopsin
signalling with advancing age in retinal degeneration.
Although we have not examined BLA in neonatal animals here,
the age (8–14 days old) at which rats were used in the initial studies
by Crozier and Pincus [1] strongly implicates the involvement of
the melanopsin system. This is because outer retinal function does
not contribute to retinal activation prior to postnatal day 10 in
mice [59] and between postnatal days 12–14 in rats [60].
An important component of our behavioural paradigm is the
direct comparison between behaviour in light versus complete
darkness. This method takes advantage of a phenomenon
whereby, in the absence of light, animals will choose to spend
the majority of a 30 minute period in the front half of the arena.
The incorporation of this behaviour into our data analysis may
help to explain why light aversion has not been reported
previously over short durations in retinally degenerate rodents.
The light:dark choice test is regarded as an unconditioned
conflict paradigm, where the innate tendency for light avoidance
conflicts with the propensity of mice to explore/escape novel
places into which they are forced [6,7]. To the best of our
knowledge the robust behaviour in darkness we report has not
previously been described. Although not easy to explain, we
suggest this response may relate to an anxiety state which occurs in
mice forced into a novel environment [61].
When mice are given the choice to freely explore something
new they display a behaviour known as ‘‘neophobia’’ which
involves initial retreat from and then progressive exploration of the
novelty. If mice are presented simultaneously with a familiar and
novel compartment to freely explore, they will spend approxi-
mately 75% of their time in the novel compartment. However,
when they are forced into this novel compartment the animals
display heightened anxiety levels, as measured by elevated
corticosterone [61]. Thus, in the context of the present
experiment, under complete darkness, a state of forced novelty
exists. We suggest that in the absence of the aversive stimulus of
light, mice may simply be returning to the point of entry which
they associate with escape to the home cage.
In adult nocturnal rodents, BLA may contribute to diurnal
behaviour by moving animals away from sunlight, towards
darkened nesting areas where they would sleep. In this respect,
the melanopsin-dependent temporal potentiation of BLA we
identify here may be of particular importance in increasing
motivation to leave open field environments. Given the role for
melanopsin in modulating sleep [31,32,33] it will be important to
examine the interaction between BLA and this other melanopsin-
modulated behaviour in future experiments.
Although not available in the present study, it would be
interesting to examine the performance of melanopsin aDTA mice
[12,32] in our paradigm, these mice will help to determine the
extent to which the mRGC pathway is required for BLA.
However, like the MKO mice reported here, mice with a targeted
destruction of mRGCs retain a behavioural aversion to light [18],
indicating that mRGCs are probably not an absolute requirement
for BLA.
Atropine application reveals a new element to light
perception
Atropine pre-treatment led to a significant elevation of BLA in
WT and MO mice, with both genotypes now responding to a
similar level. The effect was particularly strong on the melanopsin
component of BLA, strengthening the potentiation of this
behaviour over time. In contrast, atropine failed to enhance the
overall aversive response of MKO animals to light but did induce
a positive correlation over time. We concluded from these
experiments that BLA may normally be constrained by the PLR
and that with fully dilated pupils, enhanced light stimulation of the
retina increases the activity of outer and to a greater extent, inner
retinal photoreceptors.
In order to control for the possibility that atropine may act
independently of pupil dilation, we also added this drug to the eyes
of TKO mice, which lack a PLR. To our complete surprise, this
manipulation revealed an ability of TKOs to perceive light and
display BLA. Previous work with these animals has shown that
despite having an intact retina, they lack significant visual
responsiveness [49]. Recent preliminary data indicates that
TKO mice retain a small ERG with a spectral sensitivity matching
rod opsin [54]. We report here that atropine application
significantly enhances the b-wave component of this response
and that bilateral axotomy abolishes the atropine-induced
behavioural aversion to light exhibited by TKO mice. Thus, we
suggest that atropine augments a residual retinal response in these
animals, which is sufficient to drive BLA. In a complementary
fashion, we confirm that in the absence of atropine, enhancing
retinal light-responsiveness with ChR2 can also drive BLA in
TKO mice in the absence of a PLR. The magnitude and temporal
kinetics of this ChR2-mediated response are strikingly similar to
BLA seen in WT mice, indicating that during development, the
proximal neural circuitry for BLA can develop independently of
normal rod, cone and melanopsin signalling. Interestingly, the
behavioural effect in this experiment was achieved without
significant transfection of mRGCs identified using b-galactosidase
staining. Although this observation suggests that mRGCs may not
be the only conduits mediating BLA, new evidence revealing an
extended diversity of melanopsin expressing ganglion cells [36,62]
raises the possibility that ChR2V may have been expressed in
mRGCs that we could not detect.
During the preparation of this manuscript we became aware of
another study examining the ability of phototransduction deficient
MO mice (Gnat1
2/2, Cnga3
2/2) to perform pattern discrimina-
tion [36]. While these mice fail to respond to visual gratings in an
optokinetic tracking test, in a forced-swim test, they can learn to
use gratings of low spatial frequency to predict positive
reinforcement (presence of an escape platform), while control
TKOs (Opn4
2/2, Gnat1
2/2, Cnga3
2/2) cannot. This is accompa-
nied by grating-induced c-Fos activation in primary visual cortex.
The authors attribute these results solely to inner retinal
melanopsin cells. Although no experimental data is presented,
they also make the comment that control TKO mice retain an
ability to discriminate between two screens in the visual learning
task that vary significantly in luminance. This observation agrees
with our findings of atropine-enhanced BLA and provides an
independent account of light perception in TKO mice.
Interestingly, in another mouse model combining genetic
ablation of rods with the disabling of cone phototransduction
(Rho
2/2, Cnga3
2/2) there is no detectable ERG response [17].
This strongly implicates residual rod function in the retained visual
capabilities of TKO mice, which have the same cone mutation
(Cnga3
2/2) but possess structurally intact rods (Gnat1
2/2). This is
in line with a previous report of atypical rod function under cone-
isolating conditions [63] and cautions the use of genetic
deactivation without cell death in order to isolate melanopsin
function [32]. Indeed, it could be that because rods play an
important role in rodent visual acuity within the photopic range
[11], the melanopsin system may in fact be potentiating a rod-
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of mice lacking both Gnat1
2/2 and Cnga3
2/2 [36].
In terms of a mechanism of action for atropine in enhancing
light-mediated BLA, it seems likely that there is a combination of
pupillary dilation to spatially increase retinal luminance and a
direct action on retinal signal processing. Interestingly, this
information may be processed in the brain independently of
established nociceptive pathways, as atropine, applied topically to
the eyes fails to alter light-evoked responses in the spinal trigeminal
nucleus [43]. In line with our findings, another recent study also
reports that atropine (in combination with phenylepherine) can
enhance ERG b-wave amplitudes in C57 wildtype and retinal
degenerate mice [64]. The ability of atropine to enhance retinal
function has implications for the interpretation of data arising
from a range of visual neuroscience studies that employ this drug
prior to measuring visual function [12,63,65].
Relevance of BLA in mice to human photophobia
Recently, the melanopsin system has been implicated in the
circuitry by which light exacerbates the symptoms of migraine
headache [42]. This study showed that patients with outer retinal
degenerations consistently report migraine-associated photopho-
bia. Using indirect evidence the authors propose a neural circuitry
that involves information from mRGCs converging with trige-
mino-vascular signals in the lateral posterior thalamic nuclei
before the integrated information is relayed up to cortical regions
involved in pain processing.
Our results confirm that in retinal degenerate mice, melanopsin
alone can drive a progressive behavioural aversion to light which is
associated with activation of the visual and retrosplenial cortex.
Both these structures are innervated to some extent by dura/light
sensitive thalamic neurons [42]. In the context of behavioural
aversion to light, our identification of melanopsin-driven c-Fos
induction (Figure S1) in the retrosplenial cortex (RSC) is of
particular interest because stimulation of this region in humans
can cause autonomic responses linked to emotional processing
[66]. The RSC is a posterior division of the cingulate cortex [67],
a limbic structure which is active during the perception of
photophobia in humans [44]. The established role of RSC in
functions such as memory and navigation [68], together with its
anatomical connectivity to structures such as the hippocampus and
superior colliculus [69,70] make this an important structure to
examine in future studies exploring melanopsin’s role in emotional
and cognitive processing, which are widely regarded to be inter-
linked [71].
Conclusions
Melanopsin in isolation is capable of attributing emotional
salience to light sufficient to produce an aversive behavioural
response that potentiates over time. This finding has relevance to
the understanding of how spatial movements may be integrated
with diurnal sleeping patterns to control circadian behaviour.
Given the potential role for melanopsin in human photophobia,
the study of brain regions involved in assigning affective valence to
luminance represents an interesting avenue for future research.
Surprisingly, the use of atropine to examine the role of the PLR in
BLA also revealed that light perception, sufficient to generate an
aversive behavioural response can occur in TKO mice, lacking
melanopsin, a PLR and proper rod/cone function. The re-
instatement of BLA in ChR2-transfected TKO mice confirms that
pupillary constriction is not a requirement for light aversion in
rodents.
Materials and Methods
Animals
All procedures were conducted according to the Home Office
(UK) regulations, under the Animals (Scientific Procedures) Act of
1986, and with local (UCL-Institute of Ophthalmology, London,
UK) ethics committee approval.
Four types of mice were used, wildtype (WT), rd/rd cl
(melanopsin only, MO) [14,31], melanopsin knockout (MKO)
Opn4
2/2 [30] and triple knockout (TKO) Opn4
2/2;Gnat1
2/2;
Cnga3
2/2 [49]. The WT and MO are congenic on the C3H/He
strain, whilst the MKO and TKO are a C57 BL6/129 mixed
strain background. All animals were housed under a 12:12 light
dark cycle, with food and water available ad libitum.
Pupillometry
The PLR was measured in un-anaesthetised mice dark adapted
for at least 1 hour. An infra-red light source was used to illuminate
the left eye and frames were taken using a 12 bit SMD (1M60)
digital camera mounted on top of a Leica MZ75 microscope using
a magnification of 1. A long pass filter was interposed between the
microscope lens and the mouse eye to block any light of less than
665 nm wavelength. The left eye was stimulated with broad-
spectrum light originating from a xenon-arc lamp (Lambda DG-4,
Linton Instrumentation) synchronized with the image capture
using an electronic shutter (Melles-Griot). Short-pass and neutral
density filters (Edmund Optics Ltd., York, UK) were combined to
abolish stimulus light wavelengths above 600 nm. The light was
then guided with a fibre optic through a light diffuser placed 2 cm
away from the left eye stimulating with white light of 600 mW/cm
2
irradiance. The eye was stimulated for 24 seconds while collecting
spatially binned (262) frames of the eye at 4 Hz. The pupil area
was estimated off-line at each frame by an observer using
customized MATLAB software and the results were downsampled
to 1 Hz. Pupillometry was carried out on n=5 TKO, n=3 MO,
and n=4 TKO mice treated with AAV-ChR2V. One day after
PLR assessment of the TKO and MO the same mice had bilateral
application of atropine sulphate, 1%, (Minims, preservative free)
under dim red light. After 1 hour of dark adaptation recording of
their PLR was made as described above.
Testing of open field light aversion behaviour
Adult mice (,100–250 days of age) of mixed sexes were used.
We chose to use mice naı ¨ve to the experimental arena because
although habituation is used in some light/dark choice protocols
[72] this can reduce the amount of time spent in the dark [73]
which may mask subtle light responses. The open field arena is
shown in Figure 1A. The arena is square (26626 cm) and is
divided in half into an open front-half (FH) and an enclosed back-
half (BH), with a small door through which the mouse can enter
the enclosed area. The FH of the arena was either illuminated
(light FH) or remained in darkness (dark FH) with a light-
impervious cloth used to baffle the arena from stray sources of
light. White light illumination was provided by a Philips Energy
Light (Philips, Guildford UK) suspended 0.75 m above the whole
arena (irradiance at floor level 600 mW/cm
2 or ,1300 Lux). The
illumination did not cause a measurable change in temperature in
the FH of the arena compared to the BH, as measured using heat
probes. Air conditioning in the room served to regulate the
temperature and also produced background white noise.
Only naı ¨ve animals were tested, that did not have previous
exposure to the arena. All tests were carried out during the light
phase (ZT1-11) of their light:dark cycle, and all animals were light
adapted. At the start of each trial, each mouse was placed in the
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light was turned off) and left for 30 minutes with either
illumination or darkness in the FH. The time spent in each
compartment was monitored using TRUSCAN (Coulburn
Instruments, Inc Allentown, PA). After each trial the arena was
thoroughly washed and then wiped with 70% ethanol and dried.
Some animals were treated with atropine prior to being tested in
the arena. Here, animals were taken from their holding room, to a
separate procedure room where 1 drop of atropine sulphate, 1%,
(Minims, preservative free) was applied bilaterally, and the animals
were then left in their home cage for at least 0.5–2 hours prior to
being tested in a separate procedure room containing the open
field arena.
Animals that did not enter the BH of the arena within the first 5
minutes of a trial were discounted from the analysis. Total
numbers tested and those discounted are shown in table S1. In
general, most animals entered the BH within the first couple of
minutes and, in terms of latency to enter the BH, no significant
differences between the genotypes or between different illumina-
tions (light vs. darkness) were found (data not shown).
Bilateral intraocular axotomy procedure
For axotomy surgery, triple knockout mice were deeply
anaesthetized with a mixture of medetomidine hydrochloride
(1 mg/kg) (Domitor, Pfizer, Kent, UK) and ketamine (75 mg/kg)
and placed securely in a nose bar with eyes covered in ViscoTears
(Novartis Pharmaceuticals UK Ltd). An ophthalmic operating
microscope (Olympus) was used to visualize the optic nerve head
directly through a glass coverslip before gripping the extra-ocular
muscles with a pair of fine-toothed microsurgical tweezers (FST)
and inserting a 30-gauge needle (attached to a 2.5 ml Hamilton
syringe) through the sclera, directly into the sub-retinal space. This
technique uses the same needle and sub-retinal approach that is
routinely employed in cell transplantation studies [74]. Once the
needle was sub-retinal and adjacent to the optic nerve head, the
optic nerve (together with the central retinal artery) was easily
severed using a swift back and forth movement. This surgical
procedure is summarized in Figure 5A (in a schematic adapted
from May and Lutjen-Drecoll, 2002 [75]). At the time of surgery,
axotomy was confirmed by injecting 2 ml of saline to produce a
retinal detachment beneath the successfully severed optic nerve
head.
Following bilateral axotomy surgery, all animals were given an
intra-peritoneal injection of the analgesic carprofen 5 mg/kg
(Rimadyl, Pfizer, Kent, UK) and recovered with the anaesthetic
antidote atipamezole 0.5 mg/kg (Anti-sedan Pfizer, Kent, UK).
Animals had recovered well by the following morning and were
run in the light aversion assay 8 days post-surgery. One day
following the completion of behavioural testing, all mice were
perfused and their brains processed for calretinin immunohisto-
chemistry. In addition to the axotomised mice, for the purposes of
comparison, several age-matched untreated TKOs (n=3) were
also perfused and their brains processed for calretinin immuno-
histochemistry. The anatomical positioning of brain sections was
determined using the mouse brain atlas [76]. The calcium binding
protein calretinin is expressed ubiquitously in retinal ganglion cell
axons and is a well-characterised marker for assessing deafferen-
tation of subcortical retino-recipient structures in the rodent [77].
Previous work in the rat [78] and mouse [79] has demonstrated
that calretinin-positive axonal fibres in the superficial layers of
superior colliculus originate exclusively from retinal ganglion cells
and that these fibres are lost 7 days following successful optic nerve
section.
AAV vector injection
The preparation of the adeno-associated viral (AAV) vector
used here has been described in detail previously [57]. In brief, it
contains a Channelrhodopsin-2/Venus (ChR2V) fusion gene under the
control of a hybrid cytomegalovirus/chicken b actin promoter.
Four TKO adult mice (162 day-old) underwent bilateral intra-
vitreal injections of the AAV2-ChR2V viral vector suspension
(1610
12 particles/ml, measured by an ELISA assay as described
previously [80]).
Mice were anaesthetised as above and the head stabilised in a
nose-bar before inserting a 30-gauge needle (attached to a 2.5 ml
Hamilton syringe) into the vitreous cavity. A total volume of 2 ml
of the viral vector suspension was injected into each eye, followed
by a parasentesis counter-injection made below the ora serrata (to
relieve intraocular pressure). The mice were recovered as
described above and tested two-months post-surgery for photo-
phobic behaviour and pupillometry. Finally, they were perfused
and the eyes processed for immunohistochemistry, with one retina
from each animal removed and processed as a flat mount whilst
the other was cryprotected, frozen and sectioned.
Electroretinogram recordings
Experimentation was performed under dim red light
(,0.25 mW/cm
2, .650 nm), and mice were long-term dark
adapted (.12 hr) prior to recording. To compare the effects of
atropine on the TKO ERG, mice were divided into two groups: 5
mice received atropine sulphate eye drops (1%; minims,
preservative free) in each eye 30 minutes prior to recording, and
5 mice received no drops. Mice were initially anaesthetised with
intra-peritoneal ketamine (70 mg/kg) and xylazine (7 mg/kg),
which was maintained with an injection of subcutaneous ketamine
(72 mg/ml) and xylazine (5 mg/ml).
Hypromellose solution (0.5%; Alcon Laboratories, Ltd., UK)
was applied to each eye to retain corneal moisture and to provide
sufficient adherence of a contact lens electrode to the corneal
surface. A silver wire bite bar provided head support and acted as
a ground, and a needle reference electrode (AmbuH Neuroline)
was inserted approximately 5 mm from the base of contralateral
eye, sufficiently distal to exclude signal interference. Electrodes
were connected to a Windows PC via a signal conditioner (Model
1902 Mark III, CED, UK), which differentially amplified (x3000)
and filtered (band-pass filter cut-off 0.5 to 200 Hz) the signal, and
a digitizer (Model 1401, CED). Throughout experimentation, core
body temperature was maintained at ,37uC via a homeothermic
heat mat (Harvard Apparatus, Kent, UK). For ten minutes prior
to first recordings, electrode stability was monitored; electrodes
displaying any baseline instability were rejected.
A xenon arc source (Cairn Research Ltd., Kent, UK) connected
to a ganzfeld sphere provided white light flashes with a peak
corneal irradiance of 1.58 mW/cm
2 (2370 Lux). A series of 15 ms
flashes were applied using an electrically controlled mechanical
shutter (Cairn Research Ltd.) with a 40 s interstimulus interval. An
average ERG response was generated from 25 flashes, and the b-
wave amplitude measured (from a-wave peak to b-wave peak) and
compared statistically.
Immunohistochemistry
Animals were deeply anaesthetised with sodium pentobarbital
(60 mg/kg) and then perfused with 0.1 M PBS followed by 4%
paraformaldehyde (in 0.1 M phosphate buffer), with overnight
post-fixation at 4uC. Tissues to be cryostat sectioned were
cryoprotected overnight at 4uC in 30% sucrose solution (in
0.1 M PBS), and then frozen with a dry ice/acetone slurry.
Coronal brain sections (30 mm thick) were cut on the cryostat and
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(14 mm thick) and mounted onto Superfrost Plus slides (BDH,
Poole, UK).
Tissues were blocked for 2 h with 5% normal donkey serum
(NDS) in PBS containing 0.3% (retinal/brain sections) or 3% (flat
mounts) Triton X-100 (PBS-TX). The tissue was subsequently
incubated overnight in PBS-TX containing 1% NDS and either a
goat primary antibody raised against calretinin (1:1000, Swant,
Bellinzona, Switzerland) or a rabbit anti-b galactosidase antibody
(1:5,000, Abcam, Cambridge, UK). Following washes in PBS,
tissue was incubated for 2 h in PBS-TX containing 2% NDS and
an appropriate TRITC-labelled secondary antibody (1:200,
Jackson ImmunoReseach, West Grove, PA). Tissue was washed
extensively in PBS and TRIS buffer. Cell nuclei were counter-
stained with DAPI (1:5,000 Sigma) before cover-slipping with
Vectashield (Vector Laboratories, Burlingame, CA). Fluorescence
labelling was examined using a Zeiss confocal microscope (with
LSM Image Browser software, Welwyn Garden City, UK).
Statistical Analysis
All data was analysed using GraphPad Prism software
(GraphPad Software, San Diego, CA). Prior to analysis by
Student’s t-tests or ANOVA the proportional light aversion data
were transformed Y=Arcsine(Y). One-tailed Student’s t-tests were
used to analyse both the effect of light on the total amount of time
spent in the dark BH (light FH versus dark FH) over the whole 30-
minute trial, and also the electroretinogram b-wave data. To
analyse the effect of rods and cones, light aversion behaviour was
compared between the congenic WT and MO by two-way
ANOVA (factors: genotype and light) followed by Bonferroni’s
multiple comparison tests. To analyse the effect of atropine a two-
way ANOVA (factors: light and atropine) was performed followed
by Bonferroni’s multiple comparison tests. The effect of light over
the duration of the trial was investigated by using both regression
analysis and two-way repeated measures ANOVA (RM ANOVA),
factors: light and duration of the trial, (subjects were significantly
matched in all cases p,0.0001) this was followed by Bonferroni
post-tests with light FH versus dark FH at each time point in the
trial.
Supporting Information
Figure S1 Light induced c-fos in the visual and retro-
splenial cortex (RSC) of MO (rd/rd cl) mice. Images on the
left are from an animal that remained in the dark whilst those on
the right from an animal that was exposed to light. Nuclei positive
for the immediate early gene c-Fos are green, whilst neurofila-
ment-H (NF-H) is in red. (A) Montage of the cortex, 23.52 mm
from the Bregma, Scale bar 400 mm. (B) Higher magnification of
the medial visual cortex (V1/2) clearly showing light induced
neural activity in layers II–VI. (C) Higher magnification of the
retroplenial cortex showing light induced c-Fos, (B–C) Scale bars
200 mm. Methods: Mice (n=3 per condition) were dark-adapted
overnight and at 07:00, still in their home cages, either exposed to
1.5 hours of ,1300 lux white light or maintained in darkness.
They were then perfused and brain sections processed for
immunohistochemistry as described in the main text using rabbit
anti-c-fos (PC38, Calbiochem, 1:5,000) and mouse anti-neurofil-
ament heavy chain (SMI-32, Covance, 1:5,000) followed by
secondaries antibodies (FITC anti-rabbit IgG and TRITC anti-
mouse IgG, both from Jackson ImmunoReseach, West Grove,
PA). The neurofilament-H antibody was used to match up sections
using cytoarchitectural boundaries in the cortex, as described
previously by Van der Gucht et al., 2007. (TIF)
Figure S2 Behavioural light aversion in old versus
young MO (rd/rd cl) mice. (A) The amount of time old
animals (394646 day-old; mean6SD) spend in the dark back-half
(BH) during the 30-min trial is not significantly different to the
amount of time spent there by younger animals (16666 day-old),
although the average time that the old animals spend in the dark is
slightly higher (,58% versus ,46%). (B) Over the course of the
trial it is revealed that the old animals spend significantly more
time (,70%) in the dark than the younger animals during the first
5 minutes of the trial (Two-way repeated measures ANOVA
demonstrates: (1) a significant interaction (p,0.05) aging X
duration of the trial and (2) a significant effect of duration
(p,0.05), Bonferonni post-tests show that in the first 5 minutes the
old animals spend significantly more time in the dark (p,0.01)
than younger animals). It seems unlikely that this is due to poorer
mobility in the old animals as they continued to move around the
arena sampling both light and dark regions for the rest of the trial.
Due to this behaviour during the first 5-minutes there is no longer
a significant positive correlation of photophobic behaviour in the
old animals, they continue spending a similar proportion of their
time in the dark BH throughout the 30 minutes. Abbreviations:
BH, back-half; MO, melanopsin only. (TIF)
Figure S3 Calretinin positive retinal-afferents (red) are
lost 9 days post axotomy in the olivary pretectal nucleus
(OPT) and the optic chiasm (och) of TKO mice. Compare
A with B for the OPT and C with D for the och. Brain sections
from equivalent Bregma positions were imaged in control and
axotomised brains as indicated in A for the OPT and in C for the
och. Scale bar in D for all plates is 100 mm. Abbreviations: oc,
optic chiasm; OPT, olivary pretectal nucleus; TKO, triple
knockout. (TIF)
Figure S4 Pupillometry in triple knockout (TKO) mice
following transduction of the inner retina with Chan-
nelrhodopsin 2/Venus fusion protein. At two-months post-
introduction of the AAV2-ChR2V the pupillary light reflex has not
been re-instated in these animals. (TIF)
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